Rapid and Ultrarapid Opioid Detoxification Techniques
- 21 January 1998
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 279 (3) , 229-234
- https://doi.org/10.1001/jama.279.3.229
Abstract
Objective.— To review the scientific literature on the effectiveness of rapid opioid detoxification (RD) (opioid withdrawal precipitated by naloxone hydrochloride or naltrexone) and ultrarapid opioid detoxification (URD) (opioid withdrawal precipitated by naloxone or naltrexone under anesthesia or heavy sedation) techniques. Data Sources.— The MEDLINE database was searched from 1966 through 1997 using the indexing terms naloxone, naltrexone, substance dependence, and substance withdrawal syndrome. Additional data sources included bibliographies of papers identified on MEDLINE and bibliographies in textbooks on substance abuse. Study Selection.— Inclusion criteria were studies of RD or URD, pharmacologic protocols specified, and clinical outcomes specified and reported. Exclusion criteria were unpublished data, data not in peer-reviewed journals, abstract-only publications, and review articles. Data Extraction.— The methodologic characteristics of studies were extracted by the authors and summarized according to key components of research design concerning subject characteristics, therapy allocation, and outcomes assessed. Data Synthesis.— A qualitative analysis was performed on the 12 studies of RD and the 9 studies of URD identified in our search. The RD studies enrolled 641 subjects (range for individual studies, 1-162): 7 were inpatient studies, and the protocols varied considerably, as did the outcomes assessed. Three RD studies included a control group, 2 used a randomized design, and 3 reported outcomes beyond 12 days. The URD studies enrolled 424 subjects (range for individual studies, 6-300): all were inpatient studies, the detoxification and anesthesia protocols varied, 3 included a control group, 2 used a randomized design, and 2 reported outcomes for URD beyond 7 days. Conclusions.— The existing literature on RD and URD is limited in terms of the number of subjects evaluated, the variation in protocols studied, lack of randomized design and use of control groups, and the short-term nature of the outcomes reported. Further research is needed using more rigorous research methods, longer-term outcomes, and comparisons with other methods of treatment for opioid dependence.Keywords
This publication has 22 references indexed in Scilit:
- What is important in drug misuse treatment?The Lancet, 1996
- Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatmentJournal of Psychiatric Research, 1989
- Naloxone treatment for opiate withdrawal syndromeThe British Journal of Psychiatry, 1988
- Opioid Withdrawal and Naltrexone Induction in 48–72 Hours with Minimal Drop-out, Using a Modification of the Naltrexone-Clonidine TechniqueThe British Journal of Psychiatry, 1988
- Meta-Analysis in Clinical ResearchAnnals of Internal Medicine, 1987
- Clonidine and Naltrexone in the Outpatient Treatment of Heroin WithdrawalThe American Journal of Drug and Alcohol Abuse, 1987
- The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadoneAmerican Journal of Psychiatry, 1986
- The Clinical Use of Clonidine in Abrupt Withdrawal From MethadoneArchives of General Psychiatry, 1981
- Naloxone‐precipitated withdrawal: A method for rapid induction onto naltrexoneClinical Pharmacology & Therapeutics, 1977
- A Medical Treatment for Diacetylmorphine (Heroin) AddictionJAMA, 1965